Surprise! FDA officials don't want the morning-after pill sold over-the-counter because they're worried it will turn our nation's teen girls into sluts.

The Government Accountability Office has been looking into the FDA's approval process for expanding access to Plan B, and a draft of the report was just released to congressional staffers.

Washington Post reports:

When Steven Galson, then-acting director of the Center for Drug Evaluation and Research, announced the rejection, he said the decision was his own, had been recently made and was based on scientific concerns. The GAO report, however, indicates the decision was solidified months earlier and that other top officials were involved in the decision. ...

The draft GAO report indicates that Galson voiced concerns in FDA meetings about how easier availability of Plan B would effect sexual behavior by girls.

The GAO confirms that the FDA is concerned about our "morals," not our safety. Because, oddly enough, the agency didn't seem to have a problem with other drugs that were approved overwhelmingly on scientific grounds.

NPR also reported yesterday that the FDA's failure to take action on Plan B may have affected the agency's credibility. (Shocking, I know.)

Expect the full report to be made public by the end of the month. I can't wait.

UPDATE: Send the FDA your comments.